Clinical Trial Update: EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hypertension [NA]

View source ↗

Summary

The EnligHTN IV trial, a multicenter sham-controlled randomized study of renal denervation for hypertension by Abbott Medical Devices, was terminated; results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• EnligHTN Renal Denervation System (renal denervation catheter system)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Hypertension | NA | Status: TERMINATED | Results posted: 2016-03-17